Supply chain leaders should present resilience investments as business decisions that reduce measurable exposure to lost revenue, patient-care disruption, expedited freight, wasted inventory, production downtime, and slow recovery. The strongest case compares the cost of an option such as secondary sourcing, buffer capacity, better data, or contingency inventory with the financial and operational consequences of not having it when disruption occurs.

Athanasios Fourtounas, who is Assistant Professor of Project Management (PM2) and Risk Management at University of York Europe Campus, CITY and Senior Trainer at Human Asset Group, among other roles, advised leaders to connect risk management activity to visible business outcomes. "There will be fewer mistakes that will create fewer problems in your budget," he said. His broader point was that risk management can also uncover improvement opportunities, including better use of equipment, improved procedures, less waste, and stronger resource management.

A related discussion stressed that resilience spending should be evaluated against recovery performance, not only against the upfront cost of prevention. Leaders can track how quickly the organization detects an issue, assigns ownership, implements a response, and returns a critical product, service, or process to an acceptable level of performance.

Build the C-suite case around a small number of priority risks and quantify the potential operational impact of each one. Show the expected investment, the consequences of inaction, the available response options, the accountable executive owner, and the measures that will demonstrate improvement, such as avoided expedites, fewer stockouts, shorter recovery time, lower waste, or improved service continuity.

Join LogiMed to learn how healthcare supply chain leaders are linking resilience investments to financial performance, operational readiness, and continuity of patient care.